Search

Your search keyword '"He, Licai"' showing total 17 results
Start Over Author "He, Licai" Publisher american association for cancer research (aacr)
17 results on '"He, Licai"'

1. Figure S5 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

2. Table S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

3. Table S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

4. Figure S3 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

5. Data from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

6. Figure S4 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

7. Figure S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

8. Figure S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

9. Data from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

10. Table S1 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

11. Figure S5 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

12. Table S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

13. Figure S4 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

14. Figure S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

15. Figure S3 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

16. Figure S2 from Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, primary, Song, Hao, primary, Chen, Yuanzhi, primary, Xie, Jingjing, primary, Li, Zunling, primary, He, Licai, primary, Huang, Fangfang, primary, Xu, Yixiang, primary, Anami, Yasuaki, primary, Yu, Hai, primary, Yu, Chenyi, primary, Li, Leike, primary, Yuan, Zihao, primary, Xu, Xiaoying, primary, Wang, Qihui, primary, Chai, Yan, primary, Huang, Tao, primary, Shi, Yi, primary, Tsuchikama, Kyoji, primary, Liao, X. Charlene, primary, Xia, Ningshao, primary, Gao, George F., primary, Zhang, Ningyan, primary, Zhang, Cheng Cheng, primary, and An, Zhiqiang, primary

Published
2023
Full Text
View/download PDF

17. Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Author

Gui, Xun, primary, Deng, Mi, additional, Song, Hao, additional, Chen, Yuanzhi, additional, Xie, Jingjing, additional, Li, Zunling, additional, He, Licai, additional, Huang, Fangfang, additional, Xu, Yixiang, additional, Anami, Yasuaki, additional, Yu, Hai, additional, Yu, Chenyi, additional, Li, Leike, additional, Yuan, Zihao, additional, Xu, Xiaoying, additional, Wang, Qihui, additional, Chai, Yan, additional, Huang, Tao, additional, Shi, Yi, additional, Tsuchikama, Kyoji, additional, Liao, X. Charlene, additional, Xia, Ningshao, additional, Gao, George F., additional, Zhang, Ningyan, additional, Zhang, Cheng Cheng, additional, and An, Zhiqiang, additional

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results